MedTrace Logo

Exoskeleton-Assisted Walking ExoAtlet II

NCT04532723 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-08-26

No results posted yet for this study

Summary

Based on prior exoskeleton research, it was determined that 40 participants of variable height, weight and injury level would provide a significant measure of the safety and feasibility of using the ExoAtlet II in individuals with SCI for standing and walking rehabilitation therapy. Craig Hospital will be responsible for enrolling up to 30 individuals during the study duration.The inclusion criteria will be utilized to identify appropriate subjects for this study.

Conditions

  • Spinal Cord Injuries

Interventions

DEVICE

ExoAtlet II

ExoAtlet II is the second version of an exoskeleton that ExoAtlet has manufactured

Sponsors & Collaborators

  • COSMO ROBOTICS CO., Ltd

    collaborator INDUSTRY

  • Craig Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-30
Primary Completion
2023-07-31
Completion
2023-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04532723 on ClinicalTrials.gov